Different patterns of the L-histidine decarboxylase (HDC) gene expression in mice resistant and susceptible to experimental cutaneous leishmaniasis

Inflammation Research

Volumn 53, Issue 1, 2004, Pages 38-43

  Pos Z ^a   Muller K ^b,c   Novak I ^a   Buzas E ^a   Solbach, W ^b   Falus, A ^a   Laskay, T ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF LÜBECK   (Germany)

^c German Armed Forces   (Germany)

Author keywords

Histamine; L histidine decarboxylase; Leishmania major; Mast cell

Indexed keywords

HISTIDINE DECARBOXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL INFECTION; FEMALE; GENE EXPRESSION; GENE INDUCTION; HOST; INFECTION RESISTANCE; INFECTION SENSITIVITY; LEISHMANIA MAJOR; LYMPH NODE; MOUSE; NONHUMAN; PARAAORTIC LYMPH NODE; PARASITE CONTROL; RIBONUCLEASE PROTECTION ASSAY; SKIN LEISHMANIASIS;

ACUTE DISEASE; ANIMALS; AORTA; DISEASE SUSCEPTIBILITY; FEMALE; GENE EXPRESSION; HINDLIMB; HISTAMINE; HISTIDINE DECARBOXYLASE; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

EID: 1642553313     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-003-1221-5     Document Type: Article

References (50)

1. Solbach W, Laskay T. The host response to Leishmania infection. Adv. Immunol. 2000; 74: 275-317.
2. Laskay T, Diefenbach A, Rollinghoff M, Solbach W. Early parasite containment is decisive for resistance to Leishmania major infection. Eur. J. Immunol. 1995; 25: 2220-7.
3. Diefenbach A, Schindler H, Donhauser N, Lorenz E, Laskay T, MacMicking J et al. Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 1998; 8: 77-87.
4. Laskay T, Rollinghoff M, Solbach W. Natural killer cells participate in the early defense against Leishmania major infection in mice. Eur. J. Immunol. 1993; 23: 2237-41.
5. Scharton TM, Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 1993; 178: 567-77.
6. Leiby DA, Schreiber RD, Nacy CA. IFN-gamma produced in vivo during the first two days is critical for resolution of murine Leishmania major infections. Microb. Pathog. 1993; 14: 495-500.
7. Schneider E, Rolli-Derkinderen M, Arock M, Dy M. Trends in histamine research: new functions during immune responses and hematopoiesis. Trends Immunol. 2002; 23: 255-63.
8. Elenkov IJ, Webster E, Papanicolaou DA, Fleisher TA, Chrousos GP, Wilder RL. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J. Immunol. 1998; 161: 2586-93.
9. van der Pouw Kraan TC, Snijders A, Boeije LC, de Groot ER, Alewijnse AE, Leurs R et al. Histamine inhibits the production of interleukin-12 through interaction with H2 receptors. J. Clin. Invest. 1998; 102: 1866-73.
10. Horvath BV, Szalai C, Mandi Y, Laszlo V, Radvany Z, Darvas Z et al. Histamine and histamin-receptor antagonists modify gene expression and biosynthesis of interferon ? in peripheral human blood mononuclear cells and in CD19 depleted cell subsets. Immunol. Lett. 1999; 70: 95-9.
11. Takahashi HK, Yoshida A, Iwagaki H, Yoshino T, Itoh H, Morichika T et al. Histamine regulation of interleukin-18-initiating cytokine cascade is associated with down-regulation of intercellular adhesion molecule-1 expression in human peripheral blood mononuclear cells. J. Pharmacol. Exp. Ther. 2002; 300: 227-35.
12. Denkers EY, Gazzinelli RT, Martin D, Sher A. Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice. J. Exp. Med. 1993; 178: 1465-72.
13. Heninger E, Falus A, Darvas Z, Szalai C, Zsinko M, Pos Z et al. Interferon (IFN)α and IFNγ inhibit histidine-decarboxylase expression and cell proliferation of the HT168 human melanoma cell line. Inflamm. Res. 2000; 49: 393-7.
14. Hart PH, Grimbaldeston MA, Swift GJ, Jaksic A, Noonan FP, Finlay-Jones JJ. Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice J. Exp. Med. 1998; 187: 2045-53.
15. Takahashi K, Tanaka S, Ichikawa A. Effect of cimetidine on intratumoral cytokine expression in an experimental tumor. Biochem. Biophys. Res. Commun. 2001; 281: 1113-9.
16. Adams WJ, Morris DL. Pilot study - cimetidine enhances lymphocyte infiltration of human colorectal carcinoma: results of a small randomized control trial. Cancer 1997; 80(1): 15-21.
17. Penhaligon M, Anthoons J, Pilkington D, Wolstencroft RA, Bates T, Nias AH. Antimetastatic effect of cimetidine on mice bearing a C3H mouse mammary adenocarcinoma: survival and lymphocyte function studies. Clin. Exp. Metastasis 1984; 2: 37-53.
18. Lagier B, Lebel B, Bousquet J, Pene J. Different modulation by histamine of IL-4 and interferon-gamma (IFN-gamma) release according to the phenotype of human Th0, Th1 and Th2 clones. Clin. Exp. Immunol. 1997; 108: 545-51.
19. Osna N, Elliott K, Khan MM. The effects of histamine on interferon gamma production are dependent on the stimulatory signals. Int. Immunopharmacol. 2001; 1: 135-45.
20. Jutel M, Klunker S, Akdis M, Malolepszy J, Thomet OA, Zak-Nejmark T et al. Histamine upregulates Th1 and downregulates Th2 responses due to different patterns of surface histamine 1 and 2 receptor expression. Int Arch. Allergy Immunol. 2001; 124: 190-2.
21. Osna N, Elliott K, Khan MM. Regulation of interleukin-10 secretion by histamine in TH2 cells and splenocytes. Int. Immunopharmacol. 2001; 1: 85-96.
22. Jutel M, Watanabe T, Klunker S, Akdis M, Thomet OA, Malolepszy J et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 2001; 413: 420-5.
23. Caron G, Delneste Y, Roelandts E, Duez C, Bonnefoy JY, Pestel J et al. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J. Immunol. 2001; 167: 3682-6.
24. Hayashi H, Watanabe T. Histamine and its related enzymes. In Parvez SH, Naoi M, Nagatsu T, Parvez S, editors. Methods in neurotransmitter and neuropeptide research. Elsevier Science Publishers B.V. Amsterdam 1993: 111-37.
25. Muller K, Ehlers S, Solbach W, Laskay T. Novel multi-probe RNase protection assay (RPA) sets for the detection of murine chemokine gene expression. J. Immunol. Methods 2001; 249: 155-65.
26. Vester B, Muller K, Solbach W, Laskay T. Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major. Infect. Immun. 1999; 67: 3155-59.
27. Thakur A, Xue M, Stapleton F, Lloyd AR, Wakefield D, Willcox MD. Balance of pro-and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis. Infect. Immun. 2002; 70: 2187-97.
28. Solbach W, Forberg K, Kammerer E, Bogdan C, Rollinghoff M. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice. J. Immunol. 1986; 137: 702-7.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987; 162: 156-9.
30. Ohtsu H, Tanaka S, Terui T, Hori Y, Makabe-Kobayashi Y, Pejler G et al. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett. 2001; 502: 53-6.
31. Moll H, Fuchs H, Blank C, Rollinghoff M. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur. J. Immunol. 1993; 23: 1595-601.
32. Launois P, Maillard I, Pingel S, Swihart KG, Xenanos I, AchaOrbea H et al. IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 1997; 6: 541-9.
33. Malaviya R, Ross EA, MacGregor JI, Ikeda T, Little JR, Jakschik BA et al. Mast cell phagocytosis of FimH-expressing enterobacteria. J. Immunol. 1994; 152: 1907-14.
34. Sher A, Hein A, Moser G, Caulfield JP. Complement receptors promote the phagocytosis of bacteria by rat peritoneal mast cells. Lab. Invest. 1979; 41: 490-9.
35. Bidri M, Vouldoukis I, Mossalayi MD, Debre P, Guillosson JJ, Mazier D et al. Evidence for direct interaction between mast cells and Leishmania parasites. Parasite Immunol. 1997; 19: 475-83.
36. Park SJ, Cho SS, Oh JM, Han MK, Song YS, Bae HR et al. Promoted expression of mast cell-specific proteases in IgE-dependent passive cutaneous anaphylaxis responses. Clin. Chim. Acta 2001; 314: 231-6.
37. Tanaka S, Takasu Y, Mikura S, Satoh N, Ichikawa A. Antigen-independent induction of histamine synthesis by immunoglobulin E in mouse bone marrow-derived mast cells. J. Exp. Med. 2002; 196: 229-35.
38. Nissinen MJ, Panula P. Developmental patterns of histamine-like immunoreactivity in the mouse. J. Histochem. Cytochem. 1995; 43: 211-27.
39. Wershil BK, Theodos CM, Galli SJ, Titus RG. Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse. J. Immunol. 1994; 152: 4563-71.
40. Aebischer T, Moody SF, Handman E. Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect. Immun. 1993; 61: 220-6.
41. Stenger S, Donhauser N, Thuring H, Rollinghoff M, Bogdan C. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J. Exp. Med. 1996; 183: 1501-14.
42. Zwadlo-Klarwasser G, Braam U, Muhl-Zurbes P, Schmutzler W. Macrophages and lymphocytes: alternative sources of histamine. Agents Actions 1994; 41: Spec No: C99-100.
43. Schmutzler W, Bolsmann K, Zwadlo-Klarwasser G. Comparison of histamine release from human blood monocytes, lymphocytes, adenoidal and skin mast cells. Int. Arch. Allergy Immunol. 1995; 107: 194-6.
44. Shiraishi M, Hirasawa N, Oikawa S, Kobayashi Y, Ohuchi K. Analysis of histamine-producing cells at the late phase of allergic inflammation in rats. Immunology 2000; 99: 600-6.
45. Grimaldi G Jr, Soares MJ, Moriearty PL. Tissue eosinophilia and Leishmania mexicana mexicana eosinophil interactions in murine cutaneous leishmaniasis. Parasite Immunol. 1984; 6: 397-408.
46. Kumar PV, Moosavi A, Karimi M, Safaei A, Noorani H, Abdollahi B et al. Subclassification of localized Leishmania lymphadenitis in fine needle aspiration smears. Acta. Cytol. 2001; 45: 547-54.
47. Azadeh B, Sells PG, Ejeckam GC, Rampling D. Localized Leishmania lymphadenitis. Immunohistochemical studies. Am. J. Clin. Pathol. 1994; 102: 11-5.
48. Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2002; 2: 773-86.
49. Galli SJ, Zsebo KM, Geissler EN. The kit ligand, stem cell factor. Adv. Immunol. 1994; 55: 1-96.
50. Huang C, Sali A, Stevens RL. Regulation and function of mast cell proteases in inflammation. J. Clin. Immunol. 1998; 18: 169-83.